当前位置: 首页 > 详情页

Performance and validation of a simplified postoperative atrial fibrillation risk score

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Cardiology, Beijing Anzhen Hospital, CapitalMedical University, Beijing, P.R. China
出处:
ISSN:

关键词: coronary artery bypass grafting postoperative atrial fibrillation risk prediction

摘要:
BackgroundPostoperative atrial fibrillation (POAF) occurs in 20-40% patients who received isolated coronary artery cardiac bypass surgery (CABG). Several POAF risk prediction models have been developed, but none of them is widely adopted in practice. Our objective was to derive and validate a simple scoring system to estimate POAF risk after isolated CABG, using easily available clinical information. MethodsMedical records of 1,000 consecutive patients undergoing isolated CABG were reviewed. The data of first 700 patients were used for model derivation and data of the remaining 300 patients were used for model validation. Discrimination and calibration of the newly developed model were assessed. ResultsPOAF incidence in both the derivation and validation cohorts was 27.3%. Age 65, history of hypertension, heart failure, and myocardial infarction were independently associated with POAF risk. Risk scores were calculated by summing weighting points for each independent predictor. The score 3 was associated with high POAF incidence (41.1% in the derivation cohort and 44.3% in the validation cohort). The positive and negative POAF predictive value was 41.1% and 78.5%, respectively, in the derivation cohort, and 44.3% and 80.8%, respectively, in the validation cohort, when the cut-point score 3 was used. The Hosmer-Lemeshow goodness-of-fit test P-values were 0.917 and 0.894 in the derivation cohort and validation cohort, respectively. ConclusionsThis POAF risk following isolated CABG can be predicted with simple patient characteristic during the preoperative period. Patients with high risk scores (3) may constitute a target population for POAF prevention and prolonged postoperative surveillance.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 工程:生物医学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 工程:生物医学
JCR分区:
出版当年[2016]版:
Q3 ENGINEERING, BIOMEDICAL Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Q3 ENGINEERING, BIOMEDICAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Cardiology, Beijing Anzhen Hospital, CapitalMedical University, Beijing, P.R. China
通讯作者:
通讯机构: [1]Department of Cardiology, Beijing Anzhen Hospital, CapitalMedical University, Beijing, P.R. China [*1]Department of cardiology, BeijingAnzhen Hospital, No. 2AnZhen Road, ChaoYang District, 100029, Beijing,P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院